We recently published a list of Jim Cramer Says Trump’s Fed Chair Tussle Is Like “The Godfather” & Discusses These 10 Stocks.

Pharmaceutical giant Eli Lilly alleges the companies are selling illegal off-brand versions of its best-selling diabetes and ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

INDIANAPOLIS — Eli Lilly and Company says it's suing an Indianapolis-based weight loss clinic that it claims is misleading patients about drugs being sold. Lilly claims Premier Weight Loss is selling ...

Atria is a Dividend King with an impressive track record for dividend growth. Eli Lilly has been raising its dividend at a more impressive pace than Altria in recent years. Altria has an ...

Meanwhile, pharma company Eli Lilly (NYSE: LLY) offers a much lower yield of less than 1%, but its dividend growth rate has been far more impressive. Which stock is the better buy if your priority ...

Pfizer Halts Obesity-Drug Development. What It Means for Eli Lilly, Novo Nordisk. 'Bryson's in the backyard': A Masters contender comes to visit ...

Pharmaceutical powerhouse Eli Lilly (NYSE: LLY) had a banner year in 2024. The company's sales surged 32% to over $45 billion on massive growth from its GLP-1 agonist products, Mounjaro for ...

Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets, valued at more than $100 billion. Each of them has advantages, as well as dark spots in the pipeline of ...

At the burgeoning LEAP District in Lebanon, Purdue is the educational partner of Eli Lilly & Company, where the Indianapolis ... as well as in series such as IndyCar, the International Motorsports ...